HEADER TRANSCRIPTION 08-AUG-06 2J14 TITLE 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 165-441; COMPND 5 SYNONYM: PPAR-DELTA, PPAR-BETA, NUCLEAR HORMONE RECEPTOR 1, NUC1, COMPND 6 NUCI, PPARDELTA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, PPAR, KEYWDS 2 ZINC, RECEPTOR, ACTIVATOR, FATTY ACIDS, NUCLEAR PROTEIN, ALTERNATIVE KEYWDS 3 SPLICING, ZINC-FINGER, DNA-BINDING, METAL-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR R.EPPLE,M.AZIMIOARA,R.RUSSO,Y.XIE,X.WANG,C.COW,J.WITYAK,D.KARANEWSKY, AUTHOR 2 B.BURSULAYA,A.KREUSCH,T.TUNTLAND,A.GERKEN,M.ISKANDAR,E.SAEZ, AUTHOR 3 H.M.SEIDEL,S.S.TIAN REVDAT 4 13-DEC-23 2J14 1 REMARK REVDAT 3 24-FEB-09 2J14 1 VERSN REVDAT 2 27-SEP-06 2J14 1 JRNL REVDAT 1 06-SEP-06 2J14 0 JRNL AUTH R.EPPLE,M.AZIMIOARA,R.RUSSO,Y.XIE,X.WANG,C.COW,J.WITYAK, JRNL AUTH 2 D.KARANEWSKY,B.BURSULAYA,A.KREUSCH,T.TUNTLAND,A.GERKEN, JRNL AUTH 3 M.ISKANDAR,E.SAEZ,H.M.SEIDEL,S.S.TIAN JRNL TITL 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS. JRNL TITL 2 PART 2 JRNL REF BIOORG.MED.CHEM.LETT. V. 16 5488 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16931011 JRNL DOI 10.1016/J.BMCL.2006.08.052 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 899104.040 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 16148 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 801 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2498 REMARK 3 BIN R VALUE (WORKING SET) : 0.3510 REMARK 3 BIN FREE R VALUE : 0.4200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4074 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 129 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.82000 REMARK 3 B22 (A**2) : -10.90000 REMARK 3 B33 (A**2) : 15.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.55 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.66 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.180 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.800 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.880 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 34.94 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NVP_LCI765.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NVP_LCI765.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IN CHAIN A RESIDUE 207 HAS BEEN REMARK 3 MODELLED AS ALA, NOT AS HIS DUE TO INSUFFICIENT DENSITY. REMARK 4 REMARK 4 2J14 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1290029613. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16248 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 46.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.15000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.62000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2GWX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.69500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 157 REMARK 465 GLY A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 GLY A 165 REMARK 465 SER A 166 REMARK 465 GLN A 167 REMARK 465 TYR A 168 REMARK 465 ASN A 169 REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 VAL A 172 REMARK 465 ALA A 173 REMARK 465 GLY A 203 REMARK 465 LYS A 204 REMARK 465 ALA A 205 REMARK 465 GLY A 225 REMARK 465 LEU A 226 REMARK 465 VAL A 227 REMARK 465 TRP A 228 REMARK 465 LYS A 229 REMARK 465 GLN A 230 REMARK 465 LEU A 231 REMARK 465 VAL A 232 REMARK 465 ASN A 233 REMARK 465 GLY A 234 REMARK 465 TYR A 441 REMARK 465 MET B 157 REMARK 465 GLY B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 GLY B 165 REMARK 465 SER B 166 REMARK 465 GLN B 167 REMARK 465 TYR B 168 REMARK 465 ASN B 169 REMARK 465 PRO B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 172 REMARK 465 ALA B 173 REMARK 465 ASP B 174 REMARK 465 ALA B 205 REMARK 465 SER B 206 REMARK 465 HIS B 207 REMARK 465 THR B 208 REMARK 465 ALA B 209 REMARK 465 VAL B 227 REMARK 465 TRP B 228 REMARK 465 LYS B 229 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 465 VAL B 232 REMARK 465 ASN B 233 REMARK 465 GLY B 234 REMARK 465 MET B 440 REMARK 465 TYR B 441 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 207 CG ND1 CD2 CE1 NE2 REMARK 470 MET A 440 CA C O CB CG SD CE REMARK 470 ASP B 439 CA C O CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 201 5.69 -63.09 REMARK 500 HIS A 207 -72.05 168.24 REMARK 500 ASP A 215 165.82 176.79 REMARK 500 PRO A 268 -72.60 -35.98 REMARK 500 LYS A 300 -46.34 -20.01 REMARK 500 ALA A 306 61.36 39.86 REMARK 500 GLU A 424 57.47 -103.02 REMARK 500 HIS A 430 130.49 -38.59 REMARK 500 ASP A 439 -81.18 -179.33 REMARK 500 SER B 199 -72.23 -49.39 REMARK 500 THR B 202 69.19 -113.65 REMARK 500 ASP B 215 174.04 179.64 REMARK 500 PRO B 268 -97.54 -33.86 REMARK 500 SER B 296 0.20 -67.88 REMARK 500 LYS B 300 -3.34 -56.24 REMARK 500 MET B 365 -71.84 -77.12 REMARK 500 ALA B 392 58.32 -108.27 REMARK 500 TYR B 394 -4.15 75.56 REMARK 500 TYR B 437 40.41 -76.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNI A1440 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNI B1439 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 900 RELATED ID: 1Y0S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331 REMARK 900 RELATED ID: 2AWH RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 REMARK 900 RELATED ID: 2B50 RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2 REMARK 900 RELATED ID: 2BAW RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 REMARK 900 RELATED ID: 2GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 900 RELATED ID: 3GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS DBREF 2J14 A 157 164 PDB 2J14 2J14 157 164 DBREF 2J14 A 165 441 UNP Q03181 PPARB_HUMAN 165 441 DBREF 2J14 B 157 164 PDB 2J14 2J14 157 164 DBREF 2J14 B 165 441 UNP Q03181 PPARB_HUMAN 165 441 SEQRES 1 A 285 MET GLY HIS HIS HIS HIS HIS HIS GLY SER GLN TYR ASN SEQRES 2 A 285 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 3 A 285 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 4 A 285 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 5 A 285 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 6 A 285 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 7 A 285 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 8 A 285 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 9 A 285 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 10 A 285 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 11 A 285 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 12 A 285 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 13 A 285 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 14 A 285 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 15 A 285 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 16 A 285 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 17 A 285 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 18 A 285 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 19 A 285 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 20 A 285 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 21 A 285 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 22 A 285 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 285 MET GLY HIS HIS HIS HIS HIS HIS GLY SER GLN TYR ASN SEQRES 2 B 285 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 3 B 285 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 4 B 285 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 5 B 285 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 6 B 285 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 7 B 285 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 8 B 285 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 9 B 285 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 10 B 285 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 11 B 285 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 12 B 285 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 13 B 285 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 14 B 285 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 15 B 285 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 16 B 285 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 17 B 285 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 18 B 285 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 19 B 285 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 20 B 285 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 21 B 285 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 22 B 285 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR HET GNI A1440 35 HET GNI B1439 35 HETNAM GNI (3-{4-[2-(2,4-DICHLORO-PHENOXY)-ETHYLCARBAMOYL]-5- HETNAM 2 GNI PHENYL-ISOXAZOL-3-YL}-PHENYL)-ACETIC ACID FORMUL 3 GNI 2(C26 H20 CL2 N2 O5) FORMUL 5 HOH *129(H2 O) HELIX 1 1 ASP A 174 PHE A 190 1 17 HELIX 2 2 THR A 193 LEU A 201 1 9 HELIX 3 3 ASP A 215 LYS A 224 1 10 HELIX 4 4 GLU A 240 ILE A 267 1 28 HELIX 5 5 ILE A 267 LEU A 273 1 7 HELIX 6 6 PHE A 274 ILE A 297 1 24 HELIX 7 7 ALA A 306 GLY A 308 5 3 HELIX 8 8 ARG A 314 SER A 319 1 6 HELIX 9 9 ARG A 321 ALA A 340 1 20 HELIX 10 10 ASP A 344 LEU A 357 1 14 HELIX 11 11 ASN A 366 HIS A 389 1 24 HELIX 12 12 TYR A 394 GLU A 424 1 31 HELIX 13 13 HIS A 430 TYR A 437 1 8 HELIX 14 14 LEU B 175 PHE B 190 1 16 HELIX 15 15 THR B 193 THR B 202 1 10 HELIX 16 16 ASP B 215 LEU B 226 1 12 HELIX 17 17 GLU B 240 SER B 266 1 27 HELIX 18 18 SER B 269 LEU B 273 5 5 HELIX 19 19 PHE B 274 SER B 296 1 23 HELIX 20 20 ALA B 306 GLY B 308 5 3 HELIX 21 21 ARG B 314 LEU B 320 1 7 HELIX 22 22 ARG B 321 ALA B 340 1 20 HELIX 23 23 ASP B 344 LEU B 357 1 14 HELIX 24 24 ASN B 366 HIS B 389 1 24 HELIX 25 25 TYR B 394 GLU B 424 1 31 HELIX 26 26 HIS B 430 TYR B 437 1 8 SHEET 1 AA 4 PHE A 211 ILE A 213 0 SHEET 2 AA 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA 4 GLY A 302 VAL A 305 -1 O LEU A 303 N VAL A 312 SHEET 4 AA 4 VAL A 298 ASN A 299 -1 O ASN A 299 N GLY A 302 SHEET 1 BA 4 PHE B 211 ILE B 213 0 SHEET 2 BA 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 BA 4 GLY B 302 VAL B 305 -1 O LEU B 303 N VAL B 312 SHEET 4 BA 4 VAL B 298 ASN B 299 -1 O ASN B 299 N GLY B 302 SITE 1 AC1 18 LEU A 219 VAL A 245 PHE A 246 ARG A 248 SITE 2 AC1 18 CYS A 249 THR A 252 THR A 253 HIS A 287 SITE 3 AC1 18 LEU A 294 VAL A 298 LEU A 303 LEU A 317 SITE 4 AC1 18 ILE A 327 ILE A 328 LYS A 331 HIS A 413 SITE 5 AC1 18 MET A 417 TYR A 437 SITE 1 AC2 19 LEU B 219 VAL B 245 PHE B 246 ARG B 248 SITE 2 AC2 19 CYS B 249 THR B 252 THR B 253 HIS B 287 SITE 3 AC2 19 LEU B 294 VAL B 298 VAL B 305 VAL B 312 SITE 4 AC2 19 LEU B 317 ILE B 327 ILE B 328 LYS B 331 SITE 5 AC2 19 HIS B 413 MET B 417 TYR B 437 CRYST1 39.376 93.390 92.258 90.00 90.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025396 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010708 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010839 0.00000